Henry A.Holmes

Associate

Cleveland + 1.216.586.7185

Contacto:

Compartir

Henry Holmes represents private equity funds and privately held companies in transactions involving a variety of deal structures, including mergers, acquisitions, divestitures, and equity financings, among others. Henry also advises companies on corporate governance and general business law.

Experiencia

  • ONCAP sells medical division to BiomericsJones Day advised ONCAP in the sale by portfolio company Precision Concepts International of its medical division to Biomerics, a portfolio company of Wasatch Equity Partners.
  • Riverside portfolio company acquires Agence L.I.V. Inc.Jones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Clinical Education Alliance (CEA) of Agence L.I.V. Inc. ("LIV"), a business of developing and supporting medical education initiatives, creating medical education content, and supporting logistical organization of scientific meetings and exchanges related to the environment of medical education.
  • Riverside portfolio company acquires Human Element Solutions, LLC ("Element H")Jones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Red Nucleus of Human Element Solutions, LLC (Element H), a leading content engagement provider of meetings, events, creative communications, training, and production services for biotech and pharmaceutical teams with extensive experience supporting oncology, rare disease, and specialty therapeutic areas.
  • LUX Global Label sells company to Multi-Color CorporationJones Day advised LUX Global Label, a leading manufacturer of pressure sensitive labels, shrink sleeves, and security solutions, in its sale to Multi-Color Corporation.
  • Riverside invests in AlphaGroup Medical CommunicationsJones Day advised The Riverside Company in the acquisition and financing by portfolio company Red Nucleus of Alpha Group Medical Communications LLC, a medical communication agency renowned for delivering industry-best scientific, medical affairs and outcomes communications services.
  • Riverside portfolio company acquires assets of Commonwealth Heritage Group, Inc. (CHG)Jones Day represented The Riverside Company in connection with the acquisition by portfolio company PaleoWest of the assets of Commonwealth Heritage Group, Inc. (CHG), a Michigan-based cultural resource management consulting firm that assists clients with their need to address federal, state, and local level environmental regulations.
  • Riverside portfolio company acquires RockpointeJones Day represented The Riverside Company in connection with the acquisition by portfolio company Clinical Education Alliance (CEA) of Rockpointe, Inc., a premier healthcare education company providing accredited continuing education activities and related training for healthcare professionals.
  • Resilience Capital Partners sells Trialon Corporation to Element Materials TechnologyJones Day advised Resilience Capital Partners in the sale of Trialon, a leading provider of testing and technical services including environmental, EMC, materials and vibration testing serving primarily the transportation industry, to Element Materials Technology.
  • Deezer merges with and into I2PO S.A.Jones Day advised Deezer S.A. in the context of the SPAC transaction whereby Deezer S.A. merged with and into I2PO S.A., a French SPAC listed on the professional segment of the regulated market of Euronext Paris and the related PIPE financing.
  • RBC Real Estate Capital Corporation provides $111 million loan secured by Kennebunkport Resort Collection in Kennebunkport, MaineJones Day represented RBC Real Estate Capital Corp., a subsidiary of the Royal Bank of Canada, as administrative agent, in connection with a $111 million loan secured by a fourteen-property portfolio of resorts, hotels, and luxury residential accommodations located in Kennebunkport, Maine.
  • Riverside portfolio company acquires Transplant ConnectJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company inVita Healthcare Technologies of Transplant Connect, whose iTransplantSM software facilitates the donation, transplantation and research of human biologics (including organs, tissues, corneas and birth tissue).
    •

    Antes del envío, por favor tenga en cuenta:

    la información contenida en www.jonesday.com es para uso general y no constituye asesoramiento legal. El envío y recepción de este correo electrónico no pretenden crear una relación abogado-cliente. La información que envíe a cualquier persona de nuestra Firma no tendrá carácter confidencial o privilegiado excepto en el caso de que estemos actúando en su representación. Si envía este correo electrónico, confirma que ha leído y comprendido este aviso.